Clinical Trial Update: IV Sodium Ferric Gluconate Complex in Patients Undergoing TAVI [Phase 4]

View source ↗

Summary

Phase 4 trial update for IV sodium ferric gluconate complex in patients undergoing transcatheter aortic valve implantation (TAVI).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis
• Iron Deficiency Anemia Due to Blood Loss

Drugs mentioned

• IV sodium ferric gluconate complex (ferric gluconate)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Iron Deficiency Anemia Due to Blood Loss, Aortic Stenosis | Phase 4 | Status: UNKNOWN